Ackuaku-Dogbe Edith Mawunyo, Akpalu Josephine, Abaidoo Benjamin
Department of Surgery, Eye Unit, School of Medicine and Dentistry, University of Ghana, Accra, Ghana.
Department of Medicine and Therapeutics, School of Medicine and Dentistry, University of Ghana, Accra, Ghana.
Middle East Afr J Ophthalmol. 2017 Oct-Dec;24(4):183-189. doi: 10.4103/meajo.MEAJO_91_17.
Thyroid-associated orbitopathy (TAO), a clinical manifestation of Graves' disease, is an autoimmune disorder of the orbital and periorbital tissue. Data on the epidemiology and clinical presentation of TAO in Africa are generally scarce and unavailable in Ghana. We investigated the epidemiology and clinical features of TAO among patients with thyroid disorders attending the Korle Bu Teaching Hospital, Accra.
This was a descriptive cross-sectional study of patients diagnosed with thyroid disorders which was conducted at the endocrine and orbital clinics of the Korle Bu Teaching Hospital. Diagnosis was based on clinical features and confirmed by a thyroid function test. Data collected and analyzed included demography, systemic and ocular features of thyroid disorder, and thyroid function tests.
Of the 194 patients with thyroid disorders recruited, 117 (60.30%) had TAO. The mean age was 45.22 years (standard deviation: 13.90). The male:female ratio was 1:4.45. The most common ocular symptoms were "bulging eyes" (76/65.00%) and "puffy eyelid" (62/53.00%), and the common signs were eyelid retraction (97/82.91%) and proptosis (80/68.38%). Mild TAO was diagnosed in 64.96% of patients with only 6.84% having the severe form. The outcomes of the thyroid function test, thyroid disorder, and severity of TAO did not record any statistically significant differences.
The epidemiology is similar to those reported from other parts of the world, but the ocular presentation seems to be milder than in Caucasians.
甲状腺相关眼病(TAO)是格雷夫斯病的一种临床表现,是眼眶和眶周组织的自身免疫性疾病。关于非洲TAO的流行病学和临床表现的数据普遍稀少,加纳尚无此类数据。我们调查了阿克拉科勒布教学医院甲状腺疾病患者中TAO的流行病学和临床特征。
这是一项对诊断为甲状腺疾病患者的描述性横断面研究,在科勒布教学医院的内分泌科和眼科诊所进行。诊断基于临床特征,并通过甲状腺功能测试得以证实。收集和分析的数据包括人口统计学、甲状腺疾病的全身和眼部特征以及甲状腺功能测试。
在招募的194例甲状腺疾病患者中,117例(60.30%)患有TAO。平均年龄为45.22岁(标准差:13.90)。男女比例为1:4.45。最常见的眼部症状是“突眼”(76/65.00%)和“眼睑肿胀”(62/53.00%),常见体征是眼睑退缩(97/82.91%)和眼球突出(80/68.38%)。64.96%的患者被诊断为轻度TAO,只有6.84%的患者为重度。甲状腺功能测试结果、甲状腺疾病及TAO严重程度均未显示出任何统计学上的显著差异。
其流行病学与世界其他地区报告的相似,但眼部表现似乎比白种人更为轻微。